BBVA
SRNE

Banco Bilbao Vizcaya Argentaria’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-20,000
Closed -$125K – 788
2020
Q2 		$125K Buy
+20,000
New +$76.6K ﹤0.01% 732

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's SRNE Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2020, closing a stake of 20,000 shares — an estimated $125K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in SRNE in Q2 2020 and held it in 1 quarter. The position peaked at $125K in Q2 2020. 209 funds tracked by Wall St. Rank hold SRNE as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 20,000 Sorrento Therapeutics, Inc. shares in Q3 2020, an estimated $125K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 1 quarter.
  • Banco Bilbao Vizcaya Argentaria's Sorrento Therapeutics, Inc. position peaked at $125K in Q2 2020.
  • 209 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.